[Combination therapy with fluconazole and other QTc-prolonging drugs increase the QTc interval]

Ugeskr Laeger. 2015 Oct 5;177(41):V04150371.
[Article in Danish]

Abstract

Several drugs have a QTc-prolonging effect and are metabolized by CYP3A4. The combination of QTc-prolonging drugs may act additive of the QTc interval. The risk increases additionally by co-administration of a CYP3A4-inhibiting substrate. This case report describes an incident with QTc prolongation which was probably caused by an interaction induced by a combination of amiodarone, clarithromycin and the CYP3A4-inhibitor fluconazole.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amiodarone / adverse effects*
  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / adverse effects*
  • Antifungal Agents / therapeutic use
  • Clarithromycin / adverse effects*
  • Clarithromycin / therapeutic use
  • Combined Modality Therapy / adverse effects
  • Drug Interactions
  • Electrocardiography
  • Fluconazole / adverse effects*
  • Fluconazole / therapeutic use
  • Heart Rate / drug effects
  • Humans
  • Long QT Syndrome / chemically induced*
  • Male

Substances

  • Anti-Arrhythmia Agents
  • Anti-Bacterial Agents
  • Antifungal Agents
  • Fluconazole
  • Clarithromycin
  • Amiodarone